Joseph S. Ross
Yale University
H-index: 84
North America-United States
Top articles of Joseph S. Ross
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Research misconduct as a challenge for academic institutions and scientific journals | J Epidemiol Community Health | Cristina Candal-Pedreira Joseph S Ross Ana Marušić Alberto Ruano-Ravina | 2024/1/1 |
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive … | BMJ Medicine | Maryam Mooghali Aaron P Mitchell Joshua J Skydel Joseph S Ross Joshua D Wallach | 2024/4/1 |
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data | Journal of Pharmaceutical Policy and Practice | Omar Qureshi Reshma Ramachandran Joseph S Ross | 2024/12/31 |
Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments | JAMA | Joshua D Wallach Samuel Yoon Harry Doernberg Laura R Glick Oriana Ciani | 2024/4/22 |
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study | medRxiv | Rohan Khera Arya Aminorroaya Lovedeep Singh Dhingra Phyllis M Thangaraj Aline Pedroso Camargos | 2024/2/7 |
Derivation of an annualized claims-based major adverse cardiovascular event estimator in type 2 diabetes | JACC: Advances | Rozalina G McCoy Kavya Sindhu Swarna Yihong Deng Jeph S Herrin Joseph S Ross | 2024/4/1 |
Reforming The Medical Device Recall Process—A Call For Accountability | Kushal T Kadakia Vinay Rathi Sanket Dhruva Maryam Mooghali Claudia See | 2024 | |
Association of Race and Ethnicity With Postoperative Gabapentinoid and Opioid Prescribing Trends for Older Adults | Journal of Surgical Research | Tasce Bongiovanni Siqi Gan Emily Finlayson Joseph S Ross James D Harrison | 2024/6/1 |
Industry payments to US physicians by specialty and product type | JAMA | Ahmed Sayed Joseph S Ross John Mandrola Lisa Soleymani Lehmann Andrew J Foy | 2024/4/16 |
Comparison of industry payments to psychiatrists and psychiatric advanced practice clinicians in the USA, 2021: a cross-sectional study | BMJ open | John Havlik Lydia Ososanya Megan S Lee Syed Wahid Michael Heyang | 2024/2/1 |
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation | Journal of Clinical Epidemiology | Ashley M Hopkins Natansh D Modi Frank W Rockhold Tammy Hoffmann Bradley D Menz | 2024/3/1 |
Published research on the human health implications of climate change between 2012 and 2021: cross sectional study | BMJ medicine | Victoria L Bartlett Harry Doernberg Maryam Mooghali Ravi Gupta Joshua D Wallach | 2024 |
Intravascular Microaxial Left Ventricular Assist Device Manufacturer Payments to Cardiologists and Use of Devices | JAMA | Sanket S Dhruva Joseph S Ross Michael A Steinman Siqi Gan Sruthi Muluk | 2024/4/10 |
Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022 | JAMA dermatology | Samir Kamat Benjamin Ungar Aneesh Agarwal Joy Wan Joseph S Ross | 2023/12/20 |
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies | The Journal of Rheumatology | Joshua J Skydel Reshma Ramachandran Sakinah Suttiratana Joseph S Ross Christopher M Burns | 2024/3/1 |
Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study | BMJ open | Gita Thanarajasingam Paul Kluetz Vishal Bhatnagar Abbie Brown Elizabeth Cathcart-Rake | 2024/1/1 |
Implications for Public Health Regulation if Chevron Deference Is Overturned | JAMA | Sahil Agrawal Joseph S Ross Reshma Ramachandran | 2024/5/7 |
Measuring Equity in Readmission as a Distinct Assessment of Hospital Performance | JAMA | Katherine A Nash Himali Weerahandi Huihui Yu Arjun K Venkatesh Louisa W Holaday | 2024/1/9 |
US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion | bmj | Neeraj G Patel Ayman Mohammad Joseph S Ross Reshma Ramachandran | 2024/2/21 |
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk | Nature Cardiovascular Research | Rozalina G McCoy Jeph Herrin Kavya Sindhu Swarna Yihong Deng David M Kent | 2024/4/3 |
Co-Authors
